391
Views
7
CrossRef citations to date
0
Altmetric
Acne and other folicular diseases

Objective analysis of volume restoration in atrophic acne scars and skin pores: a split study using human stem cell-conditioned media

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 73-77 | Received 04 Feb 2019, Accepted 31 May 2019, Published online: 05 Jul 2019
 

Abstract

Background: It is anticipated that the combined treatments of ablative laser and human stem cell-conditioned media produce the synergistic effects.

Objectives: To investigated the effects of human stem cell-conditioned media (HSCM) as a post-procedural agent after fractional CO2 laser procedure in patients with atrophic acne scars and skin pores.

Method: Both cheeks of 15 subjects were treated with a fractional CO2 laser. HSCM was randomly applied to one of the resurfacing sites (T) and normal saline was applied to the other site as a control (C). During the next six days, a solution containing 80% HSCM and hyaluronic acid (HA) was applied on the treated side (T) and HA alone was applied to the control side (C). Scar volume and erythema were objectively evaluated using an Antera 3D® CS.

Result: After two months, the scar volume was reduced by 23.5% (T) versus 15.0% (C) (p = .143) and the volume of the skin pores was reduced by 37.6% (T) versus 15.9% (C) (p = .006), while the erythema was increased by 2.8% (T) versus 3.1% (C) (p = .934). Atrophic scar and the skin pores in the HSCM-applied area improved by at least 15.0% after a single treatment session, suggesting better results compared with the control side.

Conclusion: HSCM may augment the regenerative effects of fractional CO2 laser.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This study has been funded by Anterogen Inc. Seoul, Korea. However, Anterogen had no role in the data collection, data analysis, data interpretation, manuscript preparation, manuscript review or approval. This study has also been registered in National Research Institute of Health (KCT003718).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.